News

Between FY2017 and FY2021, TLA activities generated a $1.61 billion economic output and supported thousands of jobs. A new report on the economic impacts generated by the UArizona commercialization office outlines these findings and projects continued growth over the next 10 years.

Professor Jeffrey Pyun and Assistant Professor Thomas Gianetti have been recognized with new UArizona faculty awards for innovation and entrepreneurship; both demonstrated significant involvement in expanding the impact of their research to the public good through a focus on commercialization.

Around the world, countries are on the cyber-offense. UArizona researchers have invented new strategies to mitigate these attacks by helping make cybersecurity for the “internet of things” (IoT) more accessible. Based on the technology, they have launched a startup, BG Networks, to bring the invention to the public.

An optical sciences Ph.D. student has developed a new way for precisely measuring radio antenna surfaces. TLA worked with him to patent the technology and now he has launched a startup, Fringe Metrology. 

The UArizona has been selected as one of over 50 world-class institutions participating in the Novartis Global Scholars Program (NGSP). The Novartis Institutes for BioMedical Research NGSP is a competitive program designed for innovators from invited institutions to gain $1M over 3-years in funding for breakthrough science not covered by traditional grant support.

Three UArizona startups founded to commercialize university inventions have been selected to participate in the 2022 Flinn Foundation Bioscience Entrepreneurship program: NeuTherapeutics. SaiOx, Inc., and uPetsia. Only seven Arizona companies were selected for this year's program.